Adela is a Toronto-based company founded in 2020.
Adela is an active company that operates in the healthcare industry. It is based in Toronto and has received a total funding of $60,000,000. Adela's most recent funding event was a Series A round on June 30, 2021, during which the organization F-Prime Capital Partners invested in the company.
June 30, 2021
Adela (formerly DNAMx), a Toronto, Canada-based company which specializes in detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test, raised $60M in Series A funding.
The round was led by F-Prime Capital with participation from OrbiMed, Deerfield Management, Decheng Capital and RA Capital Management.
June 30, 2021
June 30, 2021
Adela (formerly DNAMx), a Toronto, Canada-based company which specializes in detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test, raised $60M in Series A funding.
The round was led by F-Prime Capital with participation from OrbiMed, Deerfield Management, Decheng Capital and RA Capital Management.